Qiagen Set to Name Jonathan Pratt as CEO as Sale Talks Progress

Qiagen NV is set to announce Jonathan Pratt as its new chief executive officer as talks with private equity firms about a sale of the European molecular testing company progress, people familiar the with matter said.